Abstract
Background and Aims: Islet autoantibodies are known markers for type 1 diabetes with an immune-mediated basis; their isotype or subclass profiles may also provide clues to changes in immune response during disease or after intervention. For ICAs and GADab, the IgG1 subclass consistently dominates in recent-onset disease. The aims of our study were to determine the isotype patterns for IA-2ab in Asian Chinese patients with autoimmune diabetes. Materials and Methods: From an initial screening of over 400 diabetes patients, 40 subjects (mean age 22.2 ± 15.8 years) with IA-2ab were enrolled for this study. IA-2ab was detected by radioimmunoassay of [35S]-labelled recombinant human IA-2ic(605 - 979). Of them, 31 (median age 15 years, range 2 - 57 years; 16 children) had clinical type 1 diabetes (that is, they required insulin at onset or within 1 year) with the majority having been recently diagnosed (< 1 year). The other 9 patients had clinical type 2 diabetes phenotype. Results: IA-2ab IgG subclasses determined with monospecific secondary antibodies showed that both type 1 diabetic adults and children had similarly non-restricted isotype patterns with a strong presence of IgG1-IA-2ab. The rank order was IgG1 > 3 > 2 > 4; 15 subjects had detectable IgG4-IA-2ab. Clonality of immune response determined with kappa/lambda chain-specific antibodies also showed a non-restricted pattern. Patients aged 38.2 ± 15.2 years with type 2 diabetes had broad patterns of isotypes - IgG1/3 was detected more frequently (n = 8) than IgG2/4 (n = 5). Of three patients on insulin treatment, one was also positive for GADab. The remaining 6 patients were on oral hypoglycaemic treatment. IA-2ab in type 2 diabetes showed a low titre compared to type 1 diabetes. Conclusions: Isotype responses to IA-2 had a strong IgG1 presence, similar to ICAs and GADab. With IgG3 subclass representation, a predominant Th1 milieu in the systemic environment is likely. There is no suggestion of differences in immune response to IA-2 between adults and children with type 1 diabetes.
Key words
IA-2 Antibodies - Isotypes - Immune-Mediated Diabetes
References
-
1
Liblau R S, Singer S M, McDevitt H O.
Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.
Immunol Today.
1995;
16
34-38
-
2
Rabinovitch A.
Immunoregulatory and cytokine imbalance in the pathogeneisis of IDDM. Therapeutic intervention by immunostimulation?.
Diabetes.
1994;
43
613-621
-
3
De Carli M, D’Elios M M, Zancuoghi G, Romagnani S, Del Prete G.
Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity.
Autoimmunity.
1994;
18
301-308
-
4
Widhe M, Ekerfelt C, Forsberg P, Bergstrom S, Ernerudh J.
IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease.
Scand J Immunol.
1998;
47
575-581
-
5
Sousa A O, Henry S, Maroja F M, Lee F K, Brum L, Singh M, Lagrange P H, Aucouturier P.
IgG subclass distribution of antibody response to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients.
Clin Exp Immunol.
1998;
111
48-55
-
6
Bonifacio E, Scirpoli M, Kredel K, Fuchtenbusch M, Ziegler A-G.
Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation.
J Immunol.
1999;
163
525-532
-
7
Pozzilli P, Di Mario U.
Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult).
Diabetes Care.
2001;
24
1460-1467
-
8
Tuomi T, Carlsson A, Li H, Isomaa A, Miettinen A, Nissen M, Ehrnstrom B-J, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen M-R, Groop L C.
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Diabetes.
1999;
48
150-157
-
9
Ng W Y, Thai A C, Lui K F, Yeo P PB, Cheah J S.
Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients.
Diabetes Res Clin Pract.
1999;
43
127-135
-
10
Ng W Y, Thai A C, Lui K F, Yeo P PB, Cheah J S.
Non-restricted immunoglobulin-G subclass islet cell antibodies in Chinese.
Autoimmunity.
1993;
15
305-309
-
11
Lan M S, Lu J, Goto Y, Notkins A L.
Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2 from human insulinoma.
DNA Cell Biol.
1994;
13
505-514
-
12
Lan M S, Wasserfall N K, Maclaren N H, Notkins A L.
IA-2, a transmembranous protein of the protein tyrosine phosphatases family, is a major autoantigen in insulin-dependent diabetes mellitus.
Proc Natl Acad Sci USA.
1996;
93
63-67
-
13
Zhang B, Lan M, Notkins A.
Autoantibodies to IA-2 in IDDM: location of major antigenic determinants.
Diabetes.
1997;
46
40-43
-
14
Dozio N, Belloni C, Girardi A M, Genovese S, Sodoyez J C, Bottazzo G F, Pozza G, Bosi E.
Heterogenous IgG subclass distribution of islet cell antibodies.
J Autoimmun.
1994;
7
45-53
-
15
Millward A, Hussain M J, Peakman M, Pyke D A, Leslie R D, Vergani D.
Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality.
Clin Exp Immunol.
1988;
71
353-356
-
16
Schatz D A, Barrett D J, Maclaren N K, Riley W J.
Polyclonal nature of islet cell antibodies in insulin-dependent diabetes.
Autoimmunity.
1988;
1
45-50
-
17
Omar M A, Srikanta S, Eisenbarth G S.
Human islet cell antibodies: immunoglobulin class and subclass distribution defined by monoclonal antibodies.
Diabetes Res.
1987;
4
155-157
-
18
Kasuga A, Shimada A, Ozawa Y, Maruyama T, Oya K, Saruta T.
IgG1 is the dominant subclass of antibody against glutamic acid decarboxylase among type 1 diabetes in Japanese.
Endocr J.
2000;
47
57-62
-
19
Petersen J S, Kulmala P, Clausen J T, Knip M, Dyrberg T, and the Childhood Diabetes in Finland Study Group.
Progression to type 1 diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase (GAD65).
Clin Immunol Immunopathol.
1999;
90
276-281
-
20
Couper J J, Harrison L C, Aldis J JE, Colman P G, Honeyman M C, Ferrante A.
IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes.
Hum Immunol.
1998;
59
493-499
-
21
Hawa M, Fava D, Medici F, Deng Y-J, Notkins A L, De Mattia G, Leslie R DG.
Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes.
Diabetes Care.
2000;
23
228-233
-
22
Seissler J, Elkamp K, Schott M, Scherbaum W A, DENIS Study Group.
IA-2 autoantibodies restricted to the IgG4 subclass are associated with protection from type 1 diabetes.
Horm Metab Res.
2002;
34
186-191
-
23
Lohmann T, Kellner K, Verlohren H-J, Krug J, Steindorf J, Scherbaum W A, Seissler J.
Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
Diabetologia.
2001;
44
1005-1010
A. C. Thai
Dept of Medicine, National University Hospital
5 Lower Kent Ridge Road · Singapore 119074 · Republic of Singapore ·
Phone: + 65-67724352
Fax: + 65-67794112
Email: mdctac@nus.edu.sg
